Abstract
The purpose of the present study was to further investigate the relationship between the DS effects of PB and those of benzodiazepines (BZs) and to begin to collect pharmacological information concerning receptor mechanisms involved in this behavioral effect of BZs. Rhesus monkeys (n=3), trained to discriminate pentobarbital (PB; 10 mg/kg, IG) from saline under a discrete-trials shock avoidance procedure, were given IG diazepam (0.3–10 mg/kg), chlordiazepoxide (1.0–30 mg/kg), or etizolam (0.3–10 mg/kg) alone and in combination with flumazenil (0.01–1.7 mg/kg, IM). Flumazenil was administered 10 min prior to the administration of saline, PB or the BZs. All three BZs fully substituted for PB in all monkeys. Diazepam was the most potent with a mean ED50 of 0.81 mg/kg (SEM=0.04) while chlordiazepoxide was the least potent (mean ED50=5.78 mg/kg, SEM=1.22 mg/kg). The ED50 for etizolam was 1.22 mg/kg (SEM=0.37 mg/kg). Pretreatment with flumazenil (0.01–1.0 mg/kg) resulted in a dose-related parallel shift to the right in the dose-response function for PB-appropriate responding in all monkeys for all three BZs. The mean (n=3) pKB value with 0.1 mg/kg flumazenil was 6.51 (SEM=0.42) for diazepam and 6.57 (SEM=0.17) for chlordiazepoxide. This value could not be calculated for etizolam because only one monkey was tested with 0.1 mg/kg flumazenil. However, the mean pKB for etizolam considering all monkeys and all doses of flumazenil was 6.58 (SEM=0.47). Apparent pA2 values for flumazenil with diazepam were 6.02 for one monkey and 7.11 for another. All three BZs tended to increase average latency to respond. Apparent pKB and pA2 analysis may prove useful for elucidating receptor mechanisms involved in the behavioral effects of BZs.
Similar content being viewed by others
References
Ator NA, Griffiths RR (1983) Lorazepam and pentobarbital drug discrimination in baboons: cross-drug generalization and interaction with Ro 15-1788. J Pharmacol Exp Ther 226:776–782
Ator NA, Griffiths RR (1986) Discriminative stimulus effects of atypical anxiolytics in baboons and rats. J Pharmacol Exp Ther 237:393–403
Barry H III, Krimmer EC (1989) Differential stimulus attributes of chlordiazepoxide and pentobarbital. Neuropharmacology 18:991–998
Bennett DA (1985) The non-sedating anxiolytic CGS 9896 produces discriminative stimuli that may be related to an anxioselective effect. Life Sci 37:703–709
Casacchia M, Bolino F, Ecari, U (1990) Etizolam in the treatment of generalized anxiety disorder: a double blind study versus placebo. Curr Med Res Opin 12:215–223
Davies MF, Onaivi ES, Chen SW, Maguire PA, Tsai NF, Loew GH (1994) Evidence for central benzodiazepine receptor heterogeneity from behavior tests. Pharmacol Biochem Behav 49:47–56
De Vry J, Slangen JL (1986) Effects of chlordiazepoxid training dose on the mixed agonist-antagonist properties of benzodiazepine receptor antagonist Ro 15-1788, in a drug discrimination procedure. Psychopharmacology 88:177–183
de Wit H, Griffiths RR (1991) Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 28:83–111
de Wit H, Pieri J, Johanson CE (1989) Reinforcing and subjective effects of diazepam in non drug-abusing volunteers. Pharmacol Biochem Behav 33:205–213
Dietrich RA, Dunwiddie TV, Harris RA, Erwin VG (1989) Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rev 41:489–537
Doble A, Martin IL (1992) Multiple benzodiazepine receptors: no reason for anxiety. Trends Pharmacol Sci 13:76–81
Dykstra LA, Bertalmio AJ, Woods JH (1988) Discriminative and analgesic effects of mu and kappa opioids: in vivo pA2 analysis. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin, pp 107–121
Evans SM, Johanson CE (1989) Discriminative stimulus properties of midazolam in the pigeon. J Pharmacol Exp Ther 248:29–38
Fracasso C, Confalonieri S, Garratini S, Caccia S (1991) Single and multiple dose pharmacokinetics of etizolam in healthy subjects. Eur J Clin Pharmacol 40:181–185
Gardner CR (1988) Pharmacological profiles in vivo of benzodiazepine receptor ligands. Drug Dev Res 12:1–28
Garza, R de la, Evans SM, Johanson CE (1987) Discriminative stimulus properties of oxazepam in the pigeon. Life Sci 40:71–79
Griffiths RR (1995) Benzodiazepines: long-term use among patients is a concern and abuse among polydrug abusers is not trivial. Psychopharmacology 118:116–117
Griffiths RR, Evans SM, Guarino JJ, Roache JD, Furman WR, Liebson I, Schwam EM (1993) Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal. J Pharmacol Exp Ther 265:1163–1174
Herling S, Shannon HE (1982) Ro 15-1788 antagonizes th discriminative stimulus effects of diazepam in rats but not similar effects of pentobarbital. Life Sci 31:2105–2112
Herling S, Valentino RJ, Winger GD (1980) Discriminative stimulus effects of pentobarbital in pigeons. Psychopharmacology 71:21–28
Holtzman, SG (1982) Phencyclidine-like discriminative stimulus properties of opioids in the squirrel monkey. Psychopharmacology 77:295–300
Holtzman, SG (1990) Discriminative stimulus effects of drugs: relationship to potential for abuse. In: Adler MW, Cowan A (eds) Testing and evaluation of drugs of abuse. Modern Methods in Pharmacology, vol. 6. Wiley-Liss, New York, pp 193–210
Holtzman SG, Steinfels GF (1994) Antagonism of the discriminative stimulus effects of the kappa-opioid agonist spiradoline. Psychopharmacology 116:243–248
Jarbe TUC (1976) Characteristics of pentobarbital discrimination in the gerbil: ransfer and antagonism. Psychopharmacology 49:33–40
Kunchandy J, Kulkarni SK (1986) Apparent pA2 estimation of benzodiazepine receptor antagonists. Methods Find Exp Clin Pharmacol 8:553–555
Mohler H (1992) GABAergic synaptic transmission. Arzneimittel-forschung 42:211–214
Nader MA, Winger G, Woods JH, Woolverton WL (1991) Discriminative and reinforcing effects of brotizolam in rhesus monkeys. Psychopharmacology 103:166–171
Negus SS, Burke TF, Medzihradsky F, Woods JH (1993) Effects of opioid agonists selective for mu, kappa, and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 267:896–903
Overton DA (1976) Discriminable effects of benzodiazepines. Psychopharmacol Commun 2:339–343
Patat A, Marcus MN, Gessel, EV, Forster A, Dubroc C, Rosenzweig P (1994) Flumazenil antagonizes the central effects of zolpidem, an imidazopyridine hypnotic. Clin Pharmacol Ther 56:430–436
Sanger DJ, Benavides J, Perrault G, Morel E, Cohen C, Joly D, Zivkovic B (1994) Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes. Neurosci Biobehav Rev 18:355–372
Shannon HE, Herling S (1983) Discriminative stimulus effects of diazepam in rats; evidence for a maximal effect. J Pharmacol Exp Ther 227:160–166
Spealman RD (1985) Discriminative-stimulus effects of midazolam in squirrel monkeys: comparison with other drugs and antagonism by RO 15-1788. J Pharmacol Exp Ther 235:456–462
Takada K, Winger G, Cook J, Larscheid P, Woods JH (1986) Discriminative and aversive properties of ß-carboline-3-carboxylic acid ethyl ester, a benzodiazepine receptor inverse agonist, in rhesus monkeys. Life Sci 38:1049–1056
Tallarida RJ, Murray RB (1981) Manual of pharmacological calculations with computer programs, Springer Berlin Heidelberg New York
Tallarida RJ, Cowan A, Adler MW (1979) pA2 and receptor differentiation: a statistical analysis of competitive antagonists. Life Sci 25:637–654
Tsumagari T, Nakajima A, Fukuda T, Shuto S, Kenjo T, Morimoto Y, Takigawa Y (1978) Pharmacological properties of Y-7131: a new anti-anxiety drug. Arzneimittelforschung 28:1158–1165
Willetts J, Balster RL (1989) Pentobarbital-like discriminative stimulus effects ofN-methyl-d-aspartate antagonists. J Pharmacol Exp Ther 249:438–443
Winger G, Herling S (1982) Discriminative stimulus effects of pentobarbital in rhesus monkeys: tests of generalization and duration of action. Psychopharmacology 76:172–176
Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39:251–491
Woods JH, Winger G, France CP (1992) Use of in vivo apparent pA2 analysis in assessment of opioid abuse liability. Trends Pharmacol Sci 13:282–286
Woolverton WL, Schuster CR (1983) Behavioral and pharmacological aspects of opioid dependence: mixed agonist-antagonists. Pharmacol Rev 35:33–52
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Woolverton, W.L., Nader, M.A. Effects of several benzodiazepines, alone and in combination with flumazenil, in rhesus monkeys trained to discriminate pentobarbital from saline. Psychopharmacology 122, 230–236 (1995). https://doi.org/10.1007/BF02246544
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246544